Good Distribution Practice (GDP) as required by Directive 2001/83/EC, Directive 2004/27/EC, EU Guidelines on Good Distribution of Medicinal Products for Human Use 94/C 63/03 and the new requirements included in the MHRA 2007 Orange Guide. It offers a practical explanation of the guidelines for those who are active in the field of setting up and implementing GDP, as well as those
involved in the management of quality systems for pharmaceutical products. It reviews GMP/GDP supply chain integrity and examines the risk of counterfeit pharmaceutical products, a growing concern today. The course also reviews sample deficiencies found by regulators and how to improve compliance in these critical areas.
involved in the management of quality systems for pharmaceutical products. It reviews GMP/GDP supply chain integrity and examines the risk of counterfeit pharmaceutical products, a growing concern today. The course also reviews sample deficiencies found by regulators and how to improve compliance in these critical areas.
